Fineotex Chemical Files Q3FY26 Monitoring Report with Revised Proceeds Data
Fineotex Chemical submitted its Q3FY26 monitoring agency report revealing significant revision in proceeds from INR 280.350 crores to INR 91.963 crores due to preferential issue undersubscription in May 2024. ICRA Limited confirmed proper utilization of INR 56.282 crores across stated objectives with no material deviations, while INR 35.682 crores remains invested in mutual funds.

*this image is generated using AI for illustrative purposes only.
Fineotex Chemical Limited has submitted its quarterly monitoring agency report for Q3FY26 to the Bombay Stock Exchange and National Stock Exchange, providing updated details on the utilization of proceeds raised through its preferential issue completed in May 2024.
Issue Details and Revised Proceeds Status
The specialty chemicals company originally planned to raise INR 280.350 crores through a preferential issue of equity shares and convertible warrants during May 13-22, 2024. However, due to undersubscription, the actual net proceeds were revised downwards to INR 91.963 crores.
| Parameter | Details |
|---|---|
| Original Issue Size | INR 280.350 crores |
| Revised Issue Size | INR 91.963 crores |
| Issue Type | Preferential Issue (Equity Shares & Convertible Warrants) |
| Issue Period | May 13-22, 2024 |
| Warrants Exercised | 13,75,000 out of 26,26,600 allotted |
| Forfeited Warrants | 12,51,600 warrants |
Monitoring Agency Assessment
ICRA Limited, appointed as the monitoring agency, confirmed that the utilization of issue proceeds remains in line with the stated objects of the issue. The report indicates no material deviations from the original plan disclosed in the offer document.
| Compliance Parameter | Status | Agency Comments |
|---|---|---|
| Utilization as per Offer Document | Yes | Cost of objects revised downwards pro-rata due to undersubscription |
| Material Deviations | Not Applicable | No comments |
| Means of Finance Changes | No | No comments |
| Major Deviations from Earlier Reports | No | No comments |
Revised Proceeds Utilization Breakdown
The company has allocated the available proceeds across three primary objectives with costs revised proportionally due to undersubscription:
| Object | Original Allocation (INR Crores) | Revised Allocation (INR Crores) | Utilized (INR Crores) | Unutilized (INR Crores) |
|---|---|---|---|---|
| Working Capital Requirement | 50.000 | 16.402 | - | 16.402 |
| Business Expansion | 161.000 | 52.813 | 46.497 | 6.316 |
| General Corporate Purposes | 69.350 | 22.749 | 9.785 | 12.964 |
| Total | 280.350 | 91.963 | 56.282 | 35.681 |
General Corporate Purpose Utilization
The report provides specific details on how general corporate purpose funds totaling INR 9.785 crores have been utilized across different quarters:
| Expense Category | Amount (INR Crores) | Quarter |
|---|---|---|
| Stock Exchange Fees & Issue Expenses | 0.195 | Q2FY2025 |
| Advisory & Professional Services | 9.104 | Q2FY2025 |
| Depository & Professional Fees | 0.103 | Q3FY2025 |
| Travelling Expenses | 0.379 | Q3FY2025 |
| Other Maintenance Expenses | 0.004 | Q3FY2025 |
Investment of Unutilized Proceeds
The company has deployed INR 35.682 crores of unutilized proceeds in mutual fund investments, generating returns of INR 0.186 crores with a market value of INR 35.867 crores as of quarter-end.
Implementation Timeline
All objects remain on schedule with completion targeted by September 30, 2030. The monitoring agency found no delays in implementation across any of the stated objectives despite the significant reduction in proceeds due to undersubscription.
The monitoring agency report emphasizes that it does not constitute commentary on the quality of issue objects or assurance on spending outcomes, but provides an objective view of proceeds utilization based on information provided by the issuer.
Historical Stock Returns for Fineotex Chemical
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.96% | -8.09% | -4.82% | -8.40% | -8.52% | +222.44% |




























